Clinical Trials & Research

Tesamorelin and Cognitive Health in Aging

Emerging research reveals tesamorelin's surprising impact on cognitive function in aging, moving beyond traditional growth hormone applications to target brain health directly.

AdminJul 2412 min

Cognitive Health & Aging

Selank Semax Stack: Cognitive Nootropic Peptides

Discover how the Selank and Semax stack cognitive nootropic peptides combination enhances mental performance beyond single-peptide use, with emerging research showing synergistic benefits for focus, anxiety, and cognitive clarity.

AdminJul 2411 min

Regulatory & Approval Status

Why BPC-157 Isn't FDA Approved Yet

After 30 years and 150 peer-reviewed publications, BPC-157 remains without FDA approval—a puzzle that reveals how regulatory pathways, funding constraints, and the absence of large-scale human trials can stall a compound indefinitely.

AdminJul 2410 min

Clinical Trials & Research

Retatrutide HbA1c Reduction Diabetes Study

Discover how retatrutide's impressive mean body weight loss complements its potential in blood sugar control, supported by the latest retatrutide HbA1c reduction diabetes study, offering new hope for managing type 2 diabetes effectively.

AdminApr 1813 min

Clinical Trials & Research

TRIUMPH Trial Retatrutide Phase 3 Obesity Study

Discover the groundbreaking TRIUMPH trial for retatrutide and its pivotal role in the phase 3 obesity journey towards FDA approval, revealing astonishing weight loss results and new hope for effective obesity treatments.

AdminApr 1811 min

Clinical Trials & Research

Retatrutide NEJM 2023 Phase 2 Obesity Results

The retatrutide NEJM 2023 phase 2 obesity trial reveals groundbreaking weight loss results, with participants losing an average of 24.2% of their body weight — but what does the data truly convey about its potential in obesity treatment?

AdminApr 1813 min